title: Does early zidovudine treatment prevent the emergency of syncytium-inducing human immunodeficiency virus?
authors.forename: M
authors.initials: M
authors.lastname: Leal
authors.forename: Y
authors.initials: Y
authors.lastname: Torres
authors.forename: F J
authors.initials: FJ
authors.lastname: Medrano
authors.forename: E J
authors.initials: EJ
authors.lastname: Calderón
authors.forename: C
authors.initials: C
authors.lastname: Rey
authors.forename: E
authors.initials: E
authors.lastname: Lissen
mesh_terms: D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003430:Cross-Sectional Studies; D005500:Follow-Up Studies; D015726:Giant Cells / Q000187:drug effects; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D015497:HIV-1; D006801:Humans; D010919:Placebos; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use*
chemical_list: D010919:Placebos; D015215:Zidovudine